南非抗逆转录病毒治疗覆盖扩大十年间晚期HIV疾病的持续负担
该研究描述南非西开普省10年间CD4细胞计数<50个/µL的晚期HIV患者数量与特征趋势,基于全省公共部门接受CD4检测的HIV患者队列。首次就诊者比例从60.9%降至26.7%,而经治患者比例从14.3%升至56.7%;2016年CD4<50个/µL者中51.8%为经治患者,其中76%可确认已停药或近期病毒血症。
要点
- 首次就诊者占CD4<50个/µL者的比例从60.9%降至26.7%,经治患者从14.3%升至56.7%
- 2016年CD4<50个/µL的经治患者中76%可确认停药或近期病毒血症
- 2016年CD4<50个/µL的经治患者中过半为男性,同年所有ART患者中约三分之一为男性
核心结论
- 当前HIV相关疾病负担主要来自经治患者未持续接受照护或未达到完全病毒学抑制。
- 作者认为,创新性干预以将ART患者留在有效照护中是当前HIV应对的基本优先事项。
研究设计与样本
- 研究为10年年度横断面CD4分布描述,数据来自南非西开普省全省公共部门所有接受CD4细胞计数检测的HIV患者队列。
- 每年对首次CD4计数<50个/µL的患者,就既往CD4和病毒载量检测、ART可及性及ART照护保留情况进行特征描述。
主要发现
- 首次接受HIV照护者初始构成CD4<50个/µL的最大群体,十年间比例从60.9%降至26.7%。
- 经治患者比例从14.3%升至56.7%。
- 2016年CD4<50个/µL患者中51.8%为经治患者,其中76%可确认已停药或近期病毒血症。
- 2016年CD4<50个/µL的经治患者中过半为男性,同年所有ART患者中约三分之一为男性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antiretroviral treatment (ART) has been massively scaled up to decrease human immunodeficiency virus (HIV)-related morbidity, mortality, and HIV transmission. However, despite documented increases in ART coverage, morbidity and mortality have remained substantial. This study describes trends in the numbers and characteristics of patients with very advanced HIV disease in the Western Cape, South Africa. METHODS: Annual cross-sectional snapshots of CD4 distributions were described over 10 years, derived from a province-wide cohort of all HIV patients receiving CD4 cell count testing in the public sector. Patients with a first CD4 count <50 cells/µL in each year were characterized with respect to prior CD4 and viral load testing, ART access, and retention in ART care. RESULTS: Patients attending HIV care for the first time initially constituted the largest group of those with CD4 count <50 cells/µL, dropping proportionally over the decade from 60.9% to 26.7%. By contrast, the proportion who were ART experienced increased from 14.3% to 56.7%. In patients with CD4 counts <50 cells/µL in 2016, 51.8% were ART experienced, of whom 76% could be confirmed to be off ART or had recent viremia. More than half who were ART experienced with a CD4 count <50 cells/µL in 2016 were men, compared to approximately one-third of all patients on ART in the same year. CONCLUSIONS: Ongoing HIV-associated morbidity now results largely from treatment-experienced patients not being in continuous care or not being fully virologically suppressed. Innovative interventions to retain ART patients in effective care are an essential priority for the ongoing HIV response.
引用
- Osler M, Hilderbrand K, Goemaere E, et al. The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa. Clin Infect Dis. 2018. PMID: 29514233. doi:10.1093/cid/cix1140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。